GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fusion Pharm FSPM · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Fusion Pharm — daily FSPM Delayed
Market value
$255
Last close × shares
Volume
300
Shares, 30 Oct 2026

About Fusion Pharm

Its shares trade under the ticker FSPM. It has been listed since 17 July 2001. In the fiscal year to 31 December 2012, it reported revenue of $808,400 and net income of $265,200. At that date it held total assets of $591,100 and shareholders' equity of $153,200.

Fusion Pharm, Inc. engages in the development and integration of a line of cultivation containers. The company is headquartered in Commerce City, Colorado. The company went IPO on 2001-07-17. The firm develops and integrates its PharmPod line of cultivation containers. The firm is a creator and manufacturer of these cultivation container systems. The firm offers PharmPlex farming solutions. The firm's PharmPods are used to cultivate a range of plants for businesses, universities and individuals. The firm's Pharmplex cultivation centers allow growing and harvesting vegetables and fruits, and distributing them. Its Pharmplex cultivation centers deliver produce within 100 miles from where they are grown.

Figures and description from our data supplier, not checked against the company's own report.

More about Fusion Pharm →

Latest on Fusion Pharm

Our reporting

Other Consumer Staples listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Fusion Pharm's ticker?

Fusion Pharm trades as FSPM on its US listing, under ISIN US36113H1005.

What was Fusion Pharm's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.